Skip to main content
. 2019 Jul 3;11(3):289–295. doi: 10.3892/mco.2019.1893

Figure 3.

Figure 3.

Plasma levels of 5-FU in the patients with different severities of adverse events at 40 h after the start of infusion. Plasma levels of 5-FU in patients with the severity of adverse events (grade <2 and ≥2) were compared at 40 h after the start of infusion. The plasma levels of 5-FU of grade <2 (n=2) and ≥2 (n=13) are expressed in box-and-whisker plots. 5-FU, 5-fluorouracil.